Almost half of TikTok videos about cholesterol miss the mark, and some can steer people into harm’s way.
Story Snapshot
- TODAY highlighted research showing many TikTok cholesterol videos are inaccurate and risky.
- Dr. Natalie Azar explained why low-density lipoprotein cholesterol drives heart risk and why lowering it helps.
- An outside review found about 40% of top TikTok cholesterol videos were wrong, with huge view counts.
- Statins often work and most people tolerate them, despite viral claims to the contrary.
TODAY’s Warning: Don’t Trust Every Viral Heart Tip
NBC’s Dr. Natalie Azar used a quick, five-minute segment to deliver a blunt message: social video is not your doctor. The piece reported that almost half of TikTok content about cholesterol is inaccurate and may be harmful, based on an analysis highlighted by the show. Azar then walked through the core science. Low-density lipoprotein cholesterol builds plaque. Plaque and inflammation trigger heart attacks and strokes. Lowering low-density lipoprotein lowers risk. That is not new. That is decades of clinical evidence.
Viewers also heard a needed reset on the “inflammation only” myth. Some influencers say cholesterol does not matter if you control inflammation. Azar countered that both factors matter. Plaque is the fuel. Inflammation is the spark. Doctors aim to remove fuel and calm the spark. That is why a treatment plan looks at diet, exercise, and often a medicine to lower low-density lipoprotein when risk is high.
What The Broader Evidence Says About TikTok
Separate reporting from a 2025 cardiology meeting found a similar pattern. Reviewers judged about 40% of the most-viewed TikTok cholesterol videos as inaccurate after screening more than 200 clips that drew over 90 million views. The details vary across studies, but the theme is steady: engaging content spreads faster than careful guidance. That gap matters when a short, slick video can push someone to ignore a statin, skip a test, or chase supplements instead of proven steps.
Platform design rewards surprise and certainty. Good medicine trades in nuance and tradeoffs. That mismatch explains why a “no, statins are poison” hot take can outrun a boring but true message like “your risk depends on your age, blood pressure, and diabetes status.” Azar emphasized that there is no single “normal” cholesterol number for every person. Risk scores and personal history steer decisions, not a one-size-fits-all cutoff.
Statins, Safety, and Common Sense
Azar addressed a steady stream of posts that claim statins wreck muscles or brains. She said most people tolerate statins well, and the drugs reduce low-density lipoprotein, lower inflammation, and cut the odds of heart attack and stroke when used for the right patient at the right dose. That point tracks with long-running clinical trials and with how cardiology teams use statins: start low, watch for side effects, adjust as needed, and pair with lifestyle changes.
On heart risk, that means getting the right facts, using tools that work, and ignoring hype. If a creator sells fear or a miracle cure, ask what they gain. If your doctor uses a risk calculator and suggests a statin because your numbers and history point to danger, ask what you stand to lose by waiting. One path offers likes. The other offers fewer funerals.
How To Judge The Next Viral Claim You See
Start with the source. A national news program that brings on a named medical expert and cites long-standing science earns more trust than an anonymous handle with a product link. TODAY’s segment pointed people to established risk tools from major heart groups and noted that plans should be tailored to each person’s profile, not to a generic number from a hashtag. When a video tells you to ignore low-density lipoprotein, remember plaque does not care about trends.
Then check the stakes. If the advice tells you to stop a medicine without a doctor’s input, that is a red flag. If it claims all heart disease is inflammation and cholesterol is a myth, that clashes with decades of clinical outcomes. When in doubt, bring the clip to your next visit and ask your clinician to walk through your 10-year and 30-year risk. A short talk grounded in your labs beats a 30-second reel every time.
